Form 4: Cognex Corp Executive Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Joerg Kuechen, Chief Technology Officer of Cognex Corp, disposed of 7,991 shares of common stock at a price of $32.9707 per share on March 11, 2025, under a pre-arranged trading plan.
Summary
- On March 11, 2025, Joerg Kuechen, the Chief Technology Officer of Cognex Corp, sold 7,991 shares of the company's common stock.
- The sale was executed at a price of $32.9707 per share.
- This transaction was conducted under a pre-arranged trading plan in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- Following the transaction, Kuechen still holds a significant number of Cognex Corp shares through direct ownership and various stock options and restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a routine stock sale by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transaction.
Industry Context
Executive stock sales are a common occurrence, especially when executed under pre-arranged trading plans like Rule 10b5-1, which allows insiders to sell shares at predetermined times and prices to avoid accusations of insider trading. The market typically views these sales in the context of the executive's overall holdings and the company's performance.
Comparison to Industry Standards
- Executive compensation and stock ownership structures at Cognex are likely benchmarked against similar technology and industrial automation companies.
- Companies like Keyence, Omron, and Teledyne Technologies are potential comparables in terms of industry focus and market capitalization.
- Analyzing executive stock ownership and trading activity across these companies can provide insights into Cognex's compensation practices and alignment of management interests with shareholders.
Stakeholder Impact
- The sale of shares by a company executive can sometimes create uncertainty among shareholders, although sales under 10b5-1 plans are generally viewed as less impactful since they are pre-planned.
- The transaction itself has a minimal direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 02/18/2018 | Date when Non-Qualified Stock Option (right to buy) at $38.39 becomes exercisable |
| 02/20/2019 | Date when Non-Qualified Stock Option (right to buy) at $56.44 becomes exercisable |
| 02/19/2020 | Date when Non-Qualified Stock Option (right to buy) at $51.49 becomes exercisable |
| 02/18/2021 | Date when Non-Qualified Stock Option (right to buy) at $50.94 becomes exercisable |
| 02/16/2022 | Date when Non-Qualified Stock Option (right to buy) at $90.5 becomes exercisable |
| 02/22/2023 | Date when Non-Qualified Stock Option (right to buy) at $64.43 becomes exercisable |
| 02/21/2024 | Date when Non-Qualified Stock Option (right to buy) at $47.21 becomes exercisable and Restricted Stock Unit becomes exercisable |
| 03/11/2025 | Date of the reported transaction: sale of 7,991 shares of common stock |
| 02/20/2025 | Date when Non-Qualified Stock Option (right to buy) at $39.44 becomes exercisable and Restricted Stock Unit becomes exercisable |
| 02/18/2026 | Date when Non-Qualified Stock Option (right to buy) at $33.04 becomes exercisable and Restricted Stock Unit becomes exercisable |
| 08/04/2026 | Date when Non-Qualified Stock Option (right to buy) at $47.95 becomes exercisable |
| 02/21/2027 | Expiration date for Non-Qualified Stock Option (right to buy) at $38.39 |
| 02/20/2028 | Expiration date for Non-Qualified Stock Option (right to buy) at $56.44 |
| 02/19/2029 | Expiration date for Non-Qualified Stock Option (right to buy) at $51.49 |
| 02/18/2030 | Expiration date for Non-Qualified Stock Option (right to buy) at $50.94 |
| 02/16/2031 | Expiration date for Non-Qualified Stock Option (right to buy) at $90.5 |
| 02/22/2032 | Expiration date for Non-Qualified Stock Option (right to buy) at $64.43 |
| 08/04/2032 | Expiration date for Non-Qualified Stock Option (right to buy) at $47.95 |
| 02/21/2033 | Expiration date for Non-Qualified Stock Option (right to buy) at $47.21 |
| 02/20/2034 | Expiration date for Non-Qualified Stock Option (right to buy) at $39.44 |
| 02/18/2035 | Expiration date for Non-Qualified Stock Option (right to buy) at $33.04 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.